Premium
Lack of strong effect modification by NFE 2L2 / CYP 3A5 / ABO of the risk of venous thrombosis associated with oral hormone therapy
Author(s) -
Blondon M.,
Wiggins K. L.,
Harrington L. B.,
Psaty B. M.,
Smith N. L.
Publication year - 2013
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.12309
Subject(s) - medicine , abo blood group system , population , venous thrombosis , thrombosis , hormone therapy , allele , endocrinology , genetics , biology , breast cancer , cancer , gene , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom